GBI Research Market Research Reports

TITLE Actions
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs
Published in Mar 2018 | US $ 4995 Onwards | By GBI Research

Summary Immune-mediated inflammatory diseases are a common set of chronic disorders that affect 5-7% of people in Western populations. Although they are often disparate in terms of their symptoms and key p...

Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018
Published in Mar 2018 | US $ 3995 Onwards | By GBI Research

This report provides an overview of the non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players acti...

Fungal Foot Infections Drug Development Pipeline Review, 2018
Published in Mar 2018 | US $ 3995 Onwards | By GBI Research

Summary This report provides an overview of the fungal foot infection pipeline landscape. It provides comprehensive information on the therapeutics under development for onychomycosis (Tinea unguium) and athlete's foot (Ti...

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs
Published in Mar 2018 | US $ 4995 Onwards | By GBI Research

Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects the joints. It is characterized by synovial inflammation and gradual bone erosion over many year...

Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer’s Disease and SMA Show Clinical and Commercial Potential
Published in Feb 2018 | US $ 4995 Onwards | By GBI Research

Summary Neurodegenerative diseases are becoming increasingly prevalent due to an aging population, but this diverse therapy area remains largely untreatable with current therapies. Neurodegenerative diseases are ch...

Antibacterial Therapeutics - High levels of Pipeline Innovation Focused on the Increasing Unmet Need Associated with Antibiotic Resistance
Published in Feb 2018 | US $ 6995 Onwards | By GBI Research

Summary Antibacterial resistance is currently believed to be responsible for over 700,000 deaths each year. As antibiotic resistance increases, due to the overuse and misuse of antibiotics, the number of avoidable deaths i...

Frontier Pharma: Women’s Health - An Expanding Therapy Area, with Endometriosis Therapies Prominent among the First-in-Class Pipeline
Published in Feb 2018 | US $ 6995 Onwards | By GBI Research

Frontier Pharma: Women’s Health - An Expanding Therapy Area, with Endometriosis Therapies Prominent among the First-in-Class Pipeline Summary The women’s health therapy area covers medical disorders that affect females only,...

Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market
Published in Feb 2018 | US $ 4995 Onwards | By GBI Research

Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market Summary Uveitis refers to inflammation of the uvea, the middle vascular...

Lower Female Reproductive System Cancers Drug Development Pipeline Review, 2017
Published in Jan 2018 | US $ 3995 Onwards | By GBI Research

This report provides an overview of the Lower Female Reproductive System Cancers pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Cervic...

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017
Published in Jan 2018 | US $ 3995 Onwards | By GBI Research

This report provides an overview of the bladder and ureter pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for these two indications, and f...

We are on:

Need Help?

Buy Any Report Avail 20% Discount. Coupon Code: OCT20